Merus: Changes in management
Dutch immuno-oncology company Merus has appointed John Crowley its Chief Financial Officer. Former CFO Shelley Margetson has been elevated to Chief Operating Officer.
Margetson has been on the management board of Merus sind June 2012 and served as CFO since 2010. Before joining Merus, Margetson served as vice president of finance of PanGenetics B.V., a therapeutic antibody development company. Margetson holds a B.A. in business economics from the Higher Economics School, is an Associate of the Chartered Institute of Management Accountants, and holds the Chartered Global Management Accountants designation.